Cold & Cough Remedies - Pakistan

  • Pakistan
  • In Pakistan, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$85.59m.
  • It is projected to experience an annual growth rate of 6.92% (CAGR 2024-2029).
  • When compared globally, the in the United States leads with the highest revenue of US$11,190.00m in 2024.
  • In terms of per person revenues, the figure stands at US$0.35 in 2024.
  • Despite the availability of traditional remedies, the demand for OTC cold and cough remedies in Pakistan continues to rise due to changing consumer preferences.

Key regions: Australia, Japan, India, Brazil, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Pakistan is experiencing significant growth and development in recent years.

Customer preferences:
Customers in Pakistan have shown a growing preference for over-the-counter cold and cough remedies. This can be attributed to several factors, including the convenience and accessibility of these products. With the busy lifestyles of many individuals, over-the-counter remedies offer a quick and easy solution to alleviate cold and cough symptoms. Additionally, the affordability of these products compared to prescription medications makes them a popular choice among consumers.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Pakistan is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking natural alternatives to traditional medications. As a result, there has been a rise in the availability and popularity of herbal remedies that are perceived to be safer and have fewer side effects.Another trend in the market is the growing popularity of combination cold and cough remedies. These products offer a convenient solution for consumers who are experiencing multiple symptoms and prefer to address them with a single medication. Combination remedies often contain a mix of ingredients that target different symptoms, such as congestion, cough, and sore throat.

Local special circumstances:
Pakistan has a high prevalence of respiratory illnesses, particularly during the winter months. This is due to various factors, including air pollution, exposure to cold temperatures, and a lack of awareness about preventive measures. As a result, the demand for cold and cough remedies is consistently high throughout the year, with a peak during the winter season.

Underlying macroeconomic factors:
The growing middle class in Pakistan is a significant driver of the Cold & Cough Remedies market. As disposable incomes increase, consumers have more purchasing power and are willing to spend on healthcare products. Additionally, the country's rapidly expanding population contributes to the growth of the market, as more individuals require access to cold and cough remedies.Furthermore, the increasing urbanization in Pakistan has led to a shift in lifestyle and healthcare preferences. Urban dwellers are more likely to seek self-medication options, such as over-the-counter remedies, due to the convenience and availability of these products in urban areas. This trend is expected to continue as urbanization rates rise in the country.In conclusion, the Cold & Cough Remedies market in Pakistan is witnessing growth and development driven by customer preferences for over-the-counter remedies, the demand for natural and herbal products, and the prevalence of respiratory illnesses. The market is supported by underlying macroeconomic factors, such as the growing middle class and urbanization in the country.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)